全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

异基因骨髓移植小鼠Treg、NK细胞及相关细胞因子与aGVHD的关系
Relationship of aGVHD with Treg, NK cells as well as their related cytokines in mice with allogeneic bone marrow transplantation

DOI: 10.7652/jdyxb201703014

Keywords: 调节性T细胞,NK细胞,急性移植物抗宿主病,细胞因子,骨髓移植
regulatory T cell
,NK cell,acute graft versus host disease,cytokine,bone marrow transplantation

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要:目的 探讨异基因骨髓移植小鼠体内调节性T细胞(Treg)、NK细胞以及与其功能相关的细胞因子白介素-10(IL-10)、转化生长因子(TGF-β)、穿孔素与急性移植物抗宿主病(aGVHD)的关系。方法 建立H-2完全不合的C57BL/6→BALB/c纯种小鼠间异基因骨髓移植后发生aGVHD模型。流式细胞仪检测移植后存活的aGVHD小鼠脾脏CD4+CD25+Treg细胞和NK-1.1+NK细胞的比例;ELISA方法检测环孢素A干预aGVHD小鼠血清IL-10、TGF-β和穿孔素的水平,以正常的C57BL/6小鼠为对照。结果 与正常小鼠相比,移植后发生aGVHD小鼠体内Treg细胞比例下降(3.6% vs. 1.55%),NK细胞比例上升(3.3% vs. 11.5%);环孢素A治疗aGVHD组小鼠,与未干预组相比,血清IL-10水平明显上升[(125.79±0.27)pg/mL vs. (103.09±3.27)pg/mL,P<0.01],TGF-β水平上升但无统计学差异[(252.05±7.84)pg/mL vs. (241.61±15.41)pg/mL,P>0.05],穿孔素水平明显上升[(186.97±4.68)pg/mL vs. (144.35±14.42)pg/mL,P<0.01]。结论 ①小鼠移植后发生aGVHD与Treg细胞比例下降有关,Treg功能相关的细胞因子IL-10、TGF-β参与环孢素A介导的免疫抑制治疗;②NK细胞参与异基因骨髓移植后aGVHD的发生过程,穿孔素的水平上升与抑制aGVHD有关。
ABSTRACT: Objective To investigate the relationship of acute graft versus host disease (aGVHD) and the regulatory T (Treg) cells, NK cells as well as their function-related cytokines such as IL-10, TGF-β, and perforin in mice with allogeneic bone marrow transplantation. Methods H-2 completely mismatched C57BL/6→BALB/c aGVHD mice model was constructed. Flow cytometry analysis was used to detect the proportion of CD4+CD25+ Treg cells and NK-1.1+ NK cells in the spleen of aGVHD mice after transplantation. ELISA method was used to detect the serum levels of IL-10, TGF-β and perforin in the aGVHD mice intervened with CSA prophylactic or not. The normal C57BL/6 mice were used as controls. Results Compared with those of normal mice, the proportion of Treg cells in aGVHD mice after transplantation was decreased (mean 3.6% vs. 1.55%) and the proportion of NK cells increased (mean 3.3% vs. 11.5%). In the aGVHD mice treated with cyclosporine A, serum IL-10 expression level was significantly increased (treated group (125.79±0.27)pg/mL, untreated group [(103.09±3.27)pg/mL, P<0.01)], TGF-β expression level was increased [(252.05±7.84)pg/mL vs. (241.61±15.41)pg/mL, P>0.05], perforin expression level was significantly increased [(186.97±4.68)pg/mL vs. (144.35±14.42)pg/mL, P<0.01]. Conclusion ① The occurrence of aGVHD is correlated with the decreased number of Treg cells after transplantation in mice. Treg cell function-related cytokines IL-10 and TGF-β are involved in the treatment of aGVHD by cyclosporine A-mediated immunosuppression. ②NK cells are involved in the occurrence of aGVHD after allogeneic bone marrow transplantation, and the increased level of perforin is related to the inhibition of aGVHD

References

[1]  PIERINI A, ALVAREZ M, NEGRIN RS. NK cell and CD4+FoxP3+ regulatory T cell based therapies for hematopoietic stem cell engraftment[J]. Stem Cells Int, 2016, 2016:9025835.
[2]  HOEPPLI RE, WU D, COOK L, et al. The environment of regulatory T cell biology: Cytokines, metabolites, and the microbiome[J]. Front Immunol, 2015, 6:61.
[3]  HOLTAN SG, PASQUINI M, WEISDORF DJ. Acute graft-versus-host disease: A bench-to-bedside update[J]. Blood, 2014, 124(3):363-373.
[4]  MIURA Y, KAMI M, TSUBOKURA M, et al. Mesenchymal stem cells for acute graft-versus-host disease[J]. Lancet, 2008, 372:715-716.
[5]  CAMPBELL DJ. Control of regulatory T cell migration, function, and homeostasis[J]. J Immunol, 2015, 195(6):2507-2513.
[6]  SCHNEIDAWIND D, PIERINI A, NEGRIN RS. Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation[J]. Blood, 2013, 122(18):3116-3121.
[7]  MARTELLI MF, DI IANNI M, RUGGERI L, et al. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse[J]. Blood, 2014, 124(4):638-644.
[8]  RUGGERI L, CAPANNI M, URBANI E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J]. Science, 2002, 295(5562):2097-2100.
[9]  CRUZ CR, BOLLARD CM. T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect[J]. Haematologica, 2015, 100(6):709-719.
[10]  MALMBERG KJ, SCHAFFER M, RINGDEN O, et al. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation[J]. Mol Immunol, 2005, 42:531-534.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133